DK0652771T3 - Tetanus-vaccinefremstilling - Google Patents

Tetanus-vaccinefremstilling

Info

Publication number
DK0652771T3
DK0652771T3 DK93910244T DK93910244T DK0652771T3 DK 0652771 T3 DK0652771 T3 DK 0652771T3 DK 93910244 T DK93910244 T DK 93910244T DK 93910244 T DK93910244 T DK 93910244T DK 0652771 T3 DK0652771 T3 DK 0652771T3
Authority
DK
Denmark
Prior art keywords
pct
vaccine production
tetanus vaccine
sec
date
Prior art date
Application number
DK93910244T
Other languages
English (en)
Other versions
DK0652771T4 (da
Inventor
Anthony James Sheppard
Peter Anthony Knight
Original Assignee
Medeva Pharma Ltd
Evans Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10719649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0652771(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medeva Pharma Ltd, Evans Vaccines Ltd filed Critical Medeva Pharma Ltd
Application granted granted Critical
Publication of DK0652771T3 publication Critical patent/DK0652771T3/da
Publication of DK0652771T4 publication Critical patent/DK0652771T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK93910244.8T 1992-07-31 1993-05-20 Tetanus-vaccinefremstilling DK0652771T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929216351A GB9216351D0 (en) 1992-07-31 1992-07-31 Vaccine production
PCT/GB1993/001037 WO1994003206A1 (en) 1992-07-31 1993-05-20 Tetanus vaccine production

Publications (2)

Publication Number Publication Date
DK0652771T3 true DK0652771T3 (da) 2001-02-26
DK0652771T4 DK0652771T4 (da) 2010-10-25

Family

ID=10719649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93910244.8T DK0652771T4 (da) 1992-07-31 1993-05-20 Tetanus-vaccinefremstilling

Country Status (14)

Country Link
US (1) US6060067A (da)
EP (1) EP0652771B2 (da)
JP (1) JP3901212B2 (da)
AT (1) ATE199059T1 (da)
AU (1) AU690518B2 (da)
CA (1) CA2141410C (da)
DE (1) DE69329922T3 (da)
DK (1) DK0652771T4 (da)
ES (1) ES2157219T5 (da)
GB (1) GB9216351D0 (da)
GR (1) GR3035683T3 (da)
NZ (1) NZ252253A (da)
PT (1) PT652771E (da)
WO (1) WO1994003206A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408094A (pt) * 2003-03-13 2006-02-14 Glaxosmithkline Biolog Sa processo para purificação de uma citolisina bacteriana, citolisina bacteriana, conjugado de polissacarìdeo capsular-pneumolisina bacteriano, composição imunogênica, vacina, processo de produção da vacina, método de tratamento ou prevenção de infecção por streptococcus pneumoniae, e, uso da pneumolisina ou do conjugado de polissacarìdeo-pneumolisina bacteriano
CN1641034B (zh) * 2004-01-14 2010-04-28 中国药品生物制品检定所 破伤风毒素重组抗原制备方法及其应用
AU2008263591C1 (en) * 2007-06-14 2013-09-26 The Secretary Of State For Health Chemically modified peptides with improved immunogenicity
GB2456549A (en) * 2008-01-18 2009-07-22 Health Prot Agency Modified botulinum neurotoxin serotype E (BoNT/E) peptides
EP2906239A1 (en) 2012-10-12 2015-08-19 GlaxoSmithKline Biologicals SA Non-cross-linked acellular pertussis antigens for use in combination vaccines
KR102388325B1 (ko) * 2016-10-20 2022-04-18 케이엠 바이올로직스 가부시키가이샤 저분자화 PRP를 사용한 Hib 컨쥬게이트 백신의 제조방법
WO2021176409A1 (en) 2020-03-05 2021-09-10 Sanofi Healthcare India Private Limited Preservative combination for vaccine composition
CN115448981A (zh) * 2022-10-20 2022-12-09 北京智飞绿竹生物制药有限公司 一种吸附破伤风疫苗的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB969772A (en) * 1961-01-05 1964-09-16 Wellcome Found Toxoids and their production
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
AU646019B2 (en) * 1990-02-12 1994-02-03 Smithkline Beecham Biologicals (Sa) Novel vaccine and method therefor

Also Published As

Publication number Publication date
ATE199059T1 (de) 2001-02-15
JPH07509481A (ja) 1995-10-19
EP0652771B2 (en) 2010-07-14
GB9216351D0 (en) 1992-09-16
GR3035683T3 (en) 2001-06-29
DE69329922T3 (de) 2010-12-09
DK0652771T4 (da) 2010-10-25
EP0652771A1 (en) 1995-05-17
CA2141410C (en) 2006-10-31
WO1994003206A1 (en) 1994-02-17
AU690518B2 (en) 1998-04-30
DE69329922T2 (de) 2001-05-23
AU4082693A (en) 1994-03-03
DE69329922D1 (de) 2001-03-15
CA2141410A1 (en) 1994-02-17
US6060067A (en) 2000-05-09
PT652771E (pt) 2001-05-31
ES2157219T3 (es) 2001-08-16
EP0652771B1 (en) 2001-02-07
NZ252253A (en) 1996-10-28
ES2157219T5 (es) 2010-10-26
JP3901212B2 (ja) 2007-04-04

Similar Documents

Publication Publication Date Title
LU91610I2 (fr) Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé)
ES2119812T3 (es) Catalasa, su produccion y uso.
DE69333065D1 (de) Alkalische lipase
NO176766C (no) Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
FI960977A (fi) Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet
DK0652771T4 (da) Tetanus-vaccinefremstilling
ATE157988T1 (de) Neuartige prolyl-endopeptidase-inhibitoren sna- 115 und sna-115t, ihre herstellung, und hierbei verwendete stämme
FI92334C (fi) Menetelmä syklosporiinien tuottamiseksi ja menetelmässä käytettävä uusi Tolypocladium-kanta
JPS56106593A (en) Alkali protease m3
NO951750D0 (no) Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme
DK0631631T3 (da) Fremgangsmåde til fremstilling af hemproteiner
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
AU673344B2 (en) Vaccines based on streptokinase
DK0456986T3 (da) Varmeresistent beta-galactosyltransferase, fremtillingsfremgangsmåde herfor og anvendelse heraf
IE32044B1 (en) Process for the manufacture of a tetanus-vaccine
RU94003337A (ru) Штамм бактерий morganella morganii - продуцент термолабильного энтеротоксина
ES2141258T3 (es) Enzima y su uso en la preparacion de acido (s)-pipecolico.
ATE223437T1 (de) Verwendung eines immunglobulinpräparates zur herstellung eines oral anzuwendenden medikaments zur prävention des hämolytischen urämischen syndroms sowie präparat hierfür
SE9403636D0 (sv) Vaccine preparation
ITMI913375A1 (it) Procedimento per la produzione di neuraminidasi
JPS572684A (en) Preparation of amylase inhibitor ai-b
RU94003328A (ru) Штамм бактерий proteus mirabilis - продуцент термолабильного энтеротоксина
TH4461EX (th) การเตรียมเอนไซม์อีลาสเทส i จากตับอ่อนของคน